Study of ammoxetine tablets in people with moderate kidney problems
Part of Kidney & urinary clinical trials.
This trial tests how a new drug called ammoxetine works in people with moderate kidney impairment compared to those with normal kidney function. It aims to find the right dose and understand how the drug is processed by the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You weigh at least 45 kg (99 lbs) if female, or 50 kg (110 lbs) if male.
- You have moderate kidney problems (as determined by your doctor) or normal kidney function.
- You are willing to use effective birth control from 2 weeks before the study until 6 months after, and not donate sperm or eggs.
- You have no history of severe allergies, heart disease, or other major medical conditions that could affect the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how the body processes ammoxetine in people with mild or moderate liver impairment compared to people with normal liver function. It aims to find out if the drug is safe and how it works in these groups.
This study tests whether a new version of an antidepressant pill is absorbed the same way as the existing one, and whether food changes how it is absorbed. Participants take the pill and have blood tests to measure drug levels.
This trial tests an investigational medication called ammoxetine for people with moderate to severe depression. It aims to see if the drug can reduce depressive symptoms and is for those who haven't had success with certain other antidepressants.
This early-stage study tests how a new experimental drug (JMKX003142) interacts with other medications in healthy volunteers. Researchers want to understand whether taking this drug with other common drugs is safe and effective.
This study tests how the body processes the experimental medicine PF-07328948 in people with different levels of kidney function. It may help find the right dose for people with kidney disease.
This study tests how the medication anaprazole sodium is processed in people with specific health conditions (liver problems, kidney problems, or older age) compared to healthy volunteers. It aims to understand the drug's safety and how it moves through the body.
Hear when a new Healthy Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.